![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0acaf27b0a4de4c33_resources-hero_cell1.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809af6100c642491b1144_resources-hero_cell2.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0c9a071f3e1315c44_resources-hero_cell3.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809aff7e7c55068ea25b5_resources-hero_cell4.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0c077d95e001f56d8_resources-hero_cell5.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0a95ec247802ff9ad_resources-hero_cell6.webp)
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jun 1, 2011
The Source Summer 2011
Magazine of the plasma protein therapeutics industry - Summer 2011
All
The Source magazine
![The Source Summer 2011](https://cdn.prod.website-files.com/6397a0a8e779b653e7149a60/647dbd1d155d0a94f97df150_Summer2011.webp)
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcfaed63418b538eb005f_Source_Summer2011-compressed.pdf
Jun 1, 2011
The Source Summer 2011
Magazine of the plasma protein therapeutics industry - Summer 2011
All
The Source magazine
![The Source Summer 2011](https://cdn.prod.website-files.com/6397a0a8e779b653e7149a60/647dbd1d155d0a94f97df150_Summer2011.webp)
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcfaed63418b538eb005f_Source_Summer2011-compressed.pdf
Mar 1, 2011
The Source Spring 2011
Magazine of the plasma protein therapeutics industry - Spring 2011
All
The Source magazine
![The Source Spring 2011](https://cdn.prod.website-files.com/6397a0a8e779b653e7149a60/647dbd11cdf8acb90fd6a883_Spring2011.webp)
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd7e65fce29368a6ebea_SOURCE_Spring%202011.pdf
Mar 1, 2011
The Source Spring 2011
Magazine of the plasma protein therapeutics industry - Spring 2011
All
The Source magazine
![The Source Spring 2011](https://cdn.prod.website-files.com/6397a0a8e779b653e7149a60/647dbd11cdf8acb90fd6a883_Spring2011.webp)
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd7e65fce29368a6ebea_SOURCE_Spring%202011.pdf
Jan 20, 2011
Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies.
Virus removal by partitioning into different fractions during cold ethanol fractionation has been described by several authors, demonstrating that cold ethanol fractionation can provide significant contribution to virus removal, even in those cases where virus removal is limited and must be supported by additional measures for virus inactivation during further processing.
All
Publication
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1537-2995.2010.03003.x
Jan 20, 2011
Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies.
Virus removal by partitioning into different fractions during cold ethanol fractionation has been described by several authors, demonstrating that cold ethanol fractionation can provide significant contribution to virus removal, even in those cases where virus removal is limited and must be supported by additional measures for virus inactivation during further processing.
All
Publication
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1537-2995.2010.03003.x
Mar 23, 2010
Human Parvovirus PARV4 and plasma protein therapies
Parvoviruses are small, non-enveloped DNA viruses that infect both vertebrate and invertebrate hosts. The human Parvovirus PARV4 has first been described in 2005 by Jones et al. For PARV4 no associated disease or specific symptoms have been observed.
All
PPTA statements
Mar 23, 2010
Human Parvovirus PARV4 and plasma protein therapies
Parvoviruses are small, non-enveloped DNA viruses that infect both vertebrate and invertebrate hosts. The human Parvovirus PARV4 has first been described in 2005 by Jones et al. For PARV4 no associated disease or specific symptoms have been observed.
All
PPTA statements
No results found